Why Decentralized Clinical Trials Are the Wave of the Future
The pandemic accelerated the use of digital and virtual technologies in clinical trials particularly around patient interaction and support. What will that mean going forward?
Jennifer Turcotte is the director of Global Life Sciences Industry at Salesforce. As part of the Healthcare and Life Sciences team, Jennifer works to bring customer success to biopharmaceutical, medical device, and diagnostic companies. She brings 10 years of industry experience having held roles in marketing, IT, and product strategy at Grail, Genentech, and Complete Genomics.
The pandemic accelerated the use of digital and virtual technologies in clinical trials particularly around patient interaction and support. What will that mean going forward?
The health crisis will have an enduring impact on the pharmaceutical industry. Here are some of the changes the industry has made to adapt, and the trends moving forward.
Successful pharmaceutical companies transform their approach and develop engagement strategies with the end-consumer in mind.
In 2020, the pharmaceutical industry continues its transition to value-based outcomes. There are five trends that are driving transformation this year.
New to Salesforce?
About Salesforce
Americas
Europe, Middle East, and Africa
© Copyright 2024 Salesforce, Inc. All rights reserved. Various trademarks held by their respective owners. Salesforce, Inc. Salesforce Tower, 415 Mission Street, 3rd Floor, San Francisco, CA 94105, United States